Search Results 2241-2250 of 21854 for platelets

1. Study Of GI-102 And PD-1 In Glioblastoma - Mayo Clinic

   Platelet count ≥100,000/mm3. Creatinine ≤1.5 x ULN OR measured or calculated creatinine clearance (per institutional standard) must be ≥45 ml/min. Total ...

2. Spine Care - Doctors - Mayo Clinic

   Min Yoo, M.D.. Physiatrist. Areas of focus: Rehabilitation therapy, Nerve block, Joint injection, Trigger point injection, Platelet rich plasma injection, ...

3. Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus - Mayo Clinic

   Inability to hold use of anti-coagulation medications or non-aspirin anti-platelet agents (APAs) for the duration recommended per ASGE guidelines for a high ...

4. Sports Medicine - Doctors - Mayo Clinic

   ... Platelet rich plasma ...injection, Musculoskeletal ultrasound, Ultrasound-guided needle electromyography, Single-fiber electromyography, Diaphragmatic ...

5. Sports Medicine - Doctors - Mayo Clinic

   ... Platelet rich plasma ...injection, Musculoskeletal ultrasound, Ultrasound-guided needle electromyography, Single-fiber electromyography, Diaphragmatic ...

6. Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer - Mayo Clinic

   Platelet count ≥100,000/mm3; Total bilirubin ≤1.5 x ULN; Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ULN (≤5 x ULN for patients ...

7. Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer - Mayo Clinic

   Platelets ≥ 100,000/mcL; Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x IULN; AST(SGOT)/ALT(SGPT) ≤ 2.5 x IULN, or ≤ 5.0 x IULN if due to liver ...

8. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

   No distant metastatic disease; Performance status - Eastern Cooperative Oncology Group (ECOG) 0-2; Absolute neutrophil count ≥ 1,500/mm^3; Platelet count ≥ ...

9. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Platelet count ≥ 100,000/mm^3. Hemoglobin ≥ 9.0 g/dL. Creatinine ≤ 1.5 x upper limit of normal (ULN). In patients with creatinine > 1.5 x ULN, if ...

10. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    Platelets ≥ 50,000 cells/mm3 (≥ 30,000 cells/mm3 if bone marrow plasma cells ≥ 50% at enrollment). Total bilirubin ≤ 1.5 x upper limit of normal (ULN) ...